Sophia Genetics SOPH
Valuation
Multiples measured against the stock's own five-year history
Near the bottom of its 5-year range · 6th percentile, 5-year average -4.0x
Near the top of its 5-year range · 98th percentile, 5-year average 3.0x
#4944 of 5329 stocks by PB (1 = cheapest)
Near the top of its 5-year range · 88th percentile, 5-year average 5.9x
#4331 of 5156 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 10.21 | – | 2.98 | 98% (pricier than usual) | #4944 of 5329 (1 = cheapest) |
| PE | -7.53 | -11.70 | -4.01 | 6% (cheaper than usual) | – |
| PS | 7.73 | 6.38 | 5.88 | 88% (pricier than usual) | #4331 of 5156 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on SOPH.
Sign in to join the discussion.